Your browser doesn't support javascript.
The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization.
Bayarri-Olmos, Rafael; Rosbjerg, Anne; Johnsen, Laust Bruun; Helgstrand, Charlotte; Bak-Thomsen, Theresa; Garred, Peter; Skjoedt, Mikkel-Ole.
  • Bayarri-Olmos R; Laboratory of Molecular Medicine, Department of Clinical Immunology, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Rosbjerg A; Laboratory of Molecular Medicine, Department of Clinical Immunology, University Hospital of Copenhagen, Copenhagen, Denmark; Institute of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Johnsen LB; Novo Nordisk A/S, Måløv, Denmark.
  • Helgstrand C; Novo Nordisk A/S, Måløv, Denmark.
  • Bak-Thomsen T; Novo Nordisk A/S, Måløv, Denmark.
  • Garred P; Laboratory of Molecular Medicine, Department of Clinical Immunology, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Skjoedt MO; Laboratory of Molecular Medicine, Department of Clinical Immunology, University Hospital of Copenhagen, Copenhagen, Denmark; Institute of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. Electronic address: moskjoedt@sund.ku.dk.
J Biol Chem ; 296: 100536, 2021.
Article in English | MEDLINE | ID: covidwho-1126904
ABSTRACT
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 from humans to animals has been reported for many domesticated species, including farmed minks. The identification of novel spike gene mutations appearing in minks has raised major concerns about potential immune evasion and challenges for the global vaccine strategy. One genetic variant, known as "cluster five," arose among farmed minks in Denmark and resulted in a complete shutdown of the world's largest mink production. However, the functional properties of this new variant are not established. Here we present functional data on the cluster-five variant, which contains a mutation resulting in a Y453F residue change in the receptor-binding domain (RBD) of the spike protein. Using an ELISA-based angiotensin-converting enzyme-2/RBD inhibition assay, we show that the Y453F variant does not decrease established humoral immunity from previously infected individuals or affect the neutralizing antibody response in a vaccine mouse model based on the original Wuhan strain RBD or spike as antigens. However, biolayer interferometry analysis demonstrates that it binds the human angiotensin-converting enzyme-2 receptor with a 4-fold higher affinity than the original strain, suggesting an enhanced transmission capacity and a possible challenge for viral control. These results also indicate that the rise in the frequency of the cluster-five variant in mink farms might be a result of the fitness advantage conferred by the receptor adaptation rather than evading immune responses.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / Spike Glycoprotein, Coronavirus / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 / Mink Type of study: Observational study Topics: Vaccines / Variants Limits: Animals / Humans Country/Region as subject: Europa Language: English Journal: J Biol Chem Year: 2021 Document Type: Article Affiliation country: J.jbc.2021.100536

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / Spike Glycoprotein, Coronavirus / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 / Mink Type of study: Observational study Topics: Vaccines / Variants Limits: Animals / Humans Country/Region as subject: Europa Language: English Journal: J Biol Chem Year: 2021 Document Type: Article Affiliation country: J.jbc.2021.100536